The partnership between Clinerion and Maxer is born

Clinerion’s Patient Network Explorer will leverage Maxer’s extended network of relations in the international healthcare sector to access promising business opportunities and expand Clinerion’s patient coverage into Italy, promoting and delivering clinical trials-related solutions.

Clinerion and Maxer will cooperate to engage clinical trial sponsors to fully exploit Patient Network Explorer’s potential and provide added-value services arising from Maxer’s experience in clinical data management, regulatory affairs, medical affairs, clinical trial disclosure and data transparency, and medical writing services.

The partners’ joint mission is to liaise with study sites to increase patient participation in trials to its full potential by offering tools to optimize protocol design, supporting the efficient start-up of local trials, and planning and consistently hitting realistic patient recruitment targets to enable the achievement of total timeline targets.

Clinerion makes real-world patient data accessible for analysis so that study protocols can be optimized with real patients in mind. It also maintains a cloud platform that brings together participants from across the clinical study ecosystem, comprising sponsors, hospitals and clinicians, and treating physicians and patients.

Maxer will support commercial and non-commercial sponsors in registering their clinical trials, uploading the results of the clinical trials on the public databases (EU and US), anonymizing the clinical data, and editing relevant scientific papers.

The geographic scope of the partnership is primarily focused on Italy, but will extend to other countries as opportunities arise.

“There are objective complementarities between Clinerion’s and Maxer’s business models,” says Massimo Zaninelli, CEO Of Maxer.” This condition lays the foundations for cooperation that will contribute to carrying out clinical studies on targeted patient populations, reducing the times and costs of implementation, and enabling innovative approaches to personalized medicine.”

“We are eager to bring the full support of our services to the patients and physicians in Italy,” says Ian Rentsch, CEO of Clinerion. “Clinerion’s Patient Network Explorer matches patients to clinical research, creating greater access to international trials for Italian trial sites and offering physicians more treatment options.”


About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments.

Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. Researchers gain access to real-time, longitudinal patient data from electronic health records for analysis. We enable pharmaceutical companies, CROs and SMOs to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s Patient Network Explorer also provides a platform for integration of diverse patient data sources into real-world data ecosystems. Clinerion’s proprietary technologies comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinerion website:

Clinerion’s Patient Network Explorer:


For more information, please contact:

Le Vin Chin

Director, Head of Marketing & Communications

Clinerion Ltd

Elisabethenanlage 11, 4051 Basel, Switzerland

Tel.: +41 61 865 60 54


Maxer Consulting

Maxer applies its pharmaceutical expertise, medical communication techniques, change management method, and training programmes to help its customers meet the continually increasing expectations for new therapeutic solutions.

Maxer business model is based on interacting with its customers in an open, collaborative, and proactive way with high standards of quality. Putting people at the centre does apply to both patients and the principle of responsibility that is part of any entrepreneurial initiative.

The creation of economic and social value is Maxer’s purpose and ensures the independence that allows operating successfully.

The constant quest for innovation guarantees that Maxer provides its clients with the most advanced solutions.

Maxer Consulting website:


For more information, please contact:

Erika Ornago

Pharma Director

Maxer Consulting srl

Via Leon Battista Alberti, 5

20149 Milan – Italy

Tel.: +39 83421186